Aehr Test Systems $AEHR Stock Position Lifted by Penbrook Management LLC

Penbrook Management LLC boosted its stake in shares of Aehr Test Systems (NASDAQ:AEHR) by 205.1% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 126,250 shares of the semiconductor company’s stock after purchasing an additional 84,875 shares during the period. Aehr Test Systems comprises approximately 1.2% of Penbrook Management LLC’s holdings, making the stock its 17th largest position. Penbrook Management LLC owned approximately 0.42% of Aehr Test Systems worth $1,632,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AEHR. GAMMA Investing LLC grew its position in Aehr Test Systems by 1,753.1% during the first quarter. GAMMA Investing LLC now owns 7,079 shares of the semiconductor company’s stock valued at $52,000 after purchasing an additional 6,697 shares in the last quarter. Rhumbline Advisers grew its position in Aehr Test Systems by 5.7% during the first quarter. Rhumbline Advisers now owns 40,212 shares of the semiconductor company’s stock valued at $293,000 after purchasing an additional 2,165 shares in the last quarter. XTX Topco Ltd bought a new stake in Aehr Test Systems in the first quarter worth approximately $267,000. Charles Schwab Investment Management Inc. grew its position in Aehr Test Systems by 4.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 225,923 shares of the semiconductor company’s stock worth $1,647,000 after acquiring an additional 10,327 shares in the last quarter. Finally, Invesco Ltd. grew its position in Aehr Test Systems by 88.8% in the first quarter. Invesco Ltd. now owns 30,226 shares of the semiconductor company’s stock worth $220,000 after acquiring an additional 14,219 shares in the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aehr Test Systems

In related news, Director Rhea J. Posedel sold 18,000 shares of the company’s stock in a transaction on Tuesday, July 22nd. The shares were sold at an average price of $19.83, for a total transaction of $356,940.00. Following the completion of the transaction, the director directly owned 71,163 shares in the company, valued at $1,411,162.29. This represents a 20.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Laura Oliphant sold 5,000 shares of the business’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $21.50, for a total transaction of $107,500.00. Following the completion of the sale, the director owned 7,665 shares in the company, valued at $164,797.50. This represents a 39.48% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,000 shares of company stock worth $687,550 in the last ninety days. 6.80% of the stock is currently owned by insiders.

Aehr Test Systems Trading Up 8.6%

Shares of Aehr Test Systems stock opened at $25.52 on Tuesday. The firm has a fifty day simple moving average of $25.26 and a 200-day simple moving average of $16.24. Aehr Test Systems has a 1-year low of $6.27 and a 1-year high of $34.35. The stock has a market capitalization of $765.86 million, a price-to-earnings ratio of -116.00 and a beta of 2.47.

Aehr Test Systems (NASDAQ:AEHR) last issued its quarterly earnings data on Monday, October 6th. The semiconductor company reported $0.01 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.01. Aehr Test Systems had a negative net margin of 11.71% and a negative return on equity of 2.41%. The business had revenue of $11.00 million during the quarter, compared to analysts’ expectations of $13.69 million. During the same period in the previous year, the company earned $0.07 earnings per share. As a group, research analysts predict that Aehr Test Systems will post 0.1 earnings per share for the current year.

Analyst Ratings Changes

AEHR has been the subject of several recent research reports. Zacks Research downgraded shares of Aehr Test Systems from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 9th. Craig Hallum downgraded shares of Aehr Test Systems from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Tuesday, October 7th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Aehr Test Systems presently has a consensus rating of “Sell” and an average target price of $24.00.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.